Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-04-11
2008-08-19
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S101000
Reexamination Certificate
active
07414051
ABSTRACT:
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
REFERENCES:
patent: 2004/0024210 (2004-02-01), Johansson et al.
patent: 2004/0138286 (2004-07-01), Imazaki et al.
patent: 2007/0037802 (2007-02-01), Elokdah et al.
patent: 2 769 914 (1999-04-01), None
patent: WO 01/09142 (2001-02-01), None
patent: WO 2004/050085 (2004-06-01), None
Russell MG and Dias R. (Curr. Top. Med. Chem, Jun. 2002; 2(6):643-54).
Chalmers (TiPS vol. 17, pp. 166-172 Apr. 1996).
Elokdah Hassan Mahmoud
Greenfield Alexander Alexei
Grosanu Cristina
Robichaud Albert Jean
Dorigo Andrea
Habte Kahsay T
Larsen Scott
Szakiel Gloria
Wyeth
LandOfFree
Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4012588